Advances on the anti-inflammatory and protective effect of AMPK activators.
- Author:
Xian-Wen PENG
1
;
Hong-Hong ZHOU
1
;
Jie DAI
2
;
Li ZHANG
1
Author Information
1. Department of Pathophysiology, Chongqing Medical University, Chongqing 400016, China.
2. Hospital of Chongqing University of Arts and Sciences, Chongqing 402160, China.
- Publication Type:Journal Article
- MeSH:
AMP-Activated Protein Kinases;
physiology;
Adiponectin;
pharmacology;
Aminoimidazole Carboxamide;
pharmacology;
Animals;
Enzyme Activation;
Inflammation;
enzymology;
Metformin;
pharmacology;
Pyrones;
pharmacology;
Thiophenes;
pharmacology
- From:
Acta Physiologica Sinica
2019;71(2):319-326
- CountryChina
- Language:Chinese
-
Abstract:
AMP-activated protein kinase (AMPK) is a key enzyme in the regulation of cellular energy homeostasis. Recent studies demonstrated that AMPK also plays an important role in the modulation of inflammation, an energy-intensive molecular response. The commonly used AMPK activators include 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and A-769662. In addition, the biological activities of metformin and adiponectin are closely related to activation of AMPK. Numerous studies have shown that these AMPK activators play an effectively protective role in animal models of acute lung injury, asthma, colitis, hepatitis, atherosclerosis and other inflammatory diseases. Therefore, AMPK activators may have promising potential for the prevention and treatment of inflammation related diseases.
